Ascendis Pharma A/s · NASDAQ:ASND
T. Rowe Price Investment Management, Inc. reported a 6.40% stake in Ascendis Pharma A/s (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
T. Rowe Price Investment Management, Inc. reported a 6.40% stake in Ascendis Pharma A/s, 3,583,546 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 3,583,546
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6.40% | 3,583,546 |
Source
Related
- Ascendis Pharma A/s
- T. Rowe Price Investment Management, Inc.
- Ascendis Pharma A/s shareholders
- Schedule 13G · T. Rowe Price Investment Management, Inc. · May 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 14, 2025
- Schedule 13G · T. Rowe Price Investment Management, Inc. · May 14, 2025
- Form 4 · Bodenhoff Mads · Sep 9, 2026
- Form 4 · Holtug Lars · Sep 3, 2026
- Form 4 · Bienaime Jean Jacques · Aug 18, 2026
- Form 4 · Smith Scott Thomas · Jun 2, 2026
- Form 4 · Bienaime Jean Jacques · Jun 1, 2026